[
  {
    "Company": "AIM Biotech",
    "Model": "Angiogenesis / Vascular Model (idenTx)",
    "Organs/Tissues": "Human microvasculature (3D vascular networks)",
    "Physiological/Pathological": "Both – normal angiogenesis or pathological (tumor vasculature)",
    "Cell Source": "Primary endothelial ± fibroblasts/pericytes",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Yes (fibroblasts often used)",
    "Tissue-resident Immune": "Optional (macrophages, etc.)",
    "Circulating Immune": "Yes (can flow T-cells in channel)",
    "Crosstalk (Multi-tissue)": "Within single chip compartments",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Collagen or Matrigel in central gel channel",
    "Notable Features": "idenTx 3, 9, or 40 microfluidic chambers, SBS format; passive or pumped flow",
    "Plate/Format (Throughput)": "idenTx 3/9/40. Low–high throughput",
    "Max Culture Duration": "~1–2 weeks typical",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Endpoint if gel digested",
    "Readouts - Whole Tissue": "In situ confocal or partial removal",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low",
    "Perfused": "Optional, gravity or external pump",
    "Gas Mix Controlled": "Incubator + gas-permeable cover",
    "Real-time Microenvironment Control": "Manual or external pump; add factors/immune cells",
    "model_availability": "Both"
  },
  {
    "Company": "AIM Biotech",
    "Model": "Tumor Microenvironment (idenTx)",
    "Organs/Tissues": "3D tumor + stroma ± vasculature",
    "Physiological/Pathological": "Pathological tumor environment, immune infiltration possible",
    "Cell Source": "Patient tumor cells or lines + fibroblasts, ± endothelium",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Yes (CAF)",
    "Tissue-resident Immune": "Possible if user adds macrophages/TILs",
    "Circulating Immune": "Yes (T cells can flow in channel)",
    "Crosstalk (Multi-tissue)": "Within chip environment",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes (collagen/Matrigel for tumor spheroid)",
    "3D Scaffold": "Yes, tumor embedded in gel channel",
    "Notable Features": "Immuno-oncology, ~2 weeks. idenTx 9 or 40 plates",
    "Plate/Format (Throughput)": "idenTx 9 or 40, medium–high throughput",
    "Max Culture Duration": "Days to ~2 weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Endpoint (gel digestion)",
    "Readouts - Whole Tissue": "On-chip confocal",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low",
    "Perfused": "Optional. Gravity or external pump",
    "Gas Mix Controlled": "Incubator-based",
    "Real-time Microenvironment Control": "Add immune cells or drugs in real time",
    "model_availability": "Both"
  },
  {
    "Company": "AIM Biotech",
    "Model": "Blood–Brain Barrier (idenTx)",
    "Organs/Tissues": "BBB (endothelium + astrocytes/pericytes)",
    "Physiological/Pathological": "Both – healthy or disrupted/inflammatory BBB",
    "Cell Source": "Human brain microvascular EC + astrocytes, pericytes",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Astrocytes/pericytes, not fibroblasts",
    "Tissue-resident Immune": "Optional microglia (not default)",
    "Circulating Immune": "Yes if T-cells flow in vascular channel",
    "Crosstalk (Multi-tissue)": "Within same chip channels",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes (hydrogel-based or 3D-lumen formation)",
    "3D Scaffold": "Yes, cylindrical channel or matrix",
    "Notable Features": "Tight barrier, drug permeability assays, idenTx plates",
    "Plate/Format (Throughput)": "idenTx 3/9/40, medium–high throughput",
    "Max Culture Duration": "1–2+ weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Gel digestion possible endpoint",
    "Readouts - Whole Tissue": "In-chip immunostaining typically",
    "Readouts - TEER": "No built-in (use dye permeability)",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low",
    "Perfused": "Static or pump if user wants flow",
    "Gas Mix Controlled": "Incubator-based",
    "Real-time Microenvironment Control": "Add triggers, immune cells, etc.",
    "model_availability": "Both"
  },
  {
    "Company": "AIM Biotech",
    "Model": "Immuno-Oncology Model (idenTx)",
    "Organs/Tissues": "Cancer + immune infiltration + vasculature",
    "Physiological/Pathological": "Tumor microenvironment, immunotherapy testing",
    "Cell Source": "Tumor cells + T/NK cells, fibroblasts, endothelium",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Yes (fibroblasts, CAFs)",
    "Tissue-resident Immune": "Possible macrophages or TILs",
    "Circulating Immune": "Yes, T-cells in channel",
    "Crosstalk (Multi-tissue)": "Local tumor-immune-vessel",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Collagen or Matrigel with tumor + vessel",
    "Notable Features": "IO assays, infiltration & killing, 9/40 chips",
    "Plate/Format (Throughput)": "idenTx 9/40, medium–high throughput",
    "Max Culture Duration": "~2 weeks for immune cytotoxic studies",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Partial at endpoint",
    "Readouts - Whole Tissue": "On-chip confocal typically",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low",
    "Perfused": "Static or gentle pump",
    "Gas Mix Controlled": "Incubator + gas-permeable",
    "Real-time Microenvironment Control": "Sequential immune cell addition, time-lapse imaging",
    "model_availability": "Both"
  },
  {
    "Company": "AIM Biotech",
    "Model": "organiX (Larger Tissue Platform)",
    "Organs/Tissues": "Variable 3D organoids or tissue aggregates",
    "Physiological/Pathological": "Both – normal or disease-specific (e.g. tumor) in bigger constructs",
    "Cell Source": "Patient-derived organoids, iPSC tissues, etc.",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Yes if fibroblasts or other support included",
    "Tissue-resident Immune": "Possible if embedded",
    "Circulating Immune": "Yes if user flows them",
    "Crosstalk (Multi-tissue)": "Typically single organ, but can link in bigger system",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Larger 3D tissue chunk in specialized well/insert",
    "Notable Features": "Supports bigger tissues, immunocompetent setups",
    "Plate/Format (Throughput)": "organiX platform (few larger wells/inserts), low–medium",
    "Max Culture Duration": "Days–weeks for large tissue viability",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes (remove 3D tissue insert)",
    "Readouts - Whole Tissue": "Yes, physically feasible to take entire piece",
    "Readouts - TEER": "No standard electrodes",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low–moderate",
    "Perfused": "Usually static or optional external flow",
    "Gas Mix Controlled": "Incubator (gas-permeable device)",
    "Real-time Microenvironment Control": "User can add immune cells, drug regimens, partial flow",
    "model_availability": "Both"
  }
]
